Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
17 clusters · 21 sources · 76 days · First seen · Last updated
Iran pharmaceutical crisis: supply chain and rising costs
Overview
Iran continues to face severe financial and liquidity pressures affecting its pharmaceutical sector. While total essential drug shortages decreased from 341 items in 2022 to approximately 65 in recent months, recent reports indicate that between 100 and 106 drugs are currently identified as having shortages or stocks lasting less than one month. Scarcity remains critical for specialized medicines for chronic diseases, including products for hemophilia and thalassemia patients. Specifically, Factor XIII is facing a severe shortage, with warnings issued regarding the depletion of emergency reserves.
The economic situation has worsened, with the Food and Drug Administration reporting that average medicine prices have increased by approximately 103% since the beginning of the current year. This has led to extreme patient hardship; Husein Zehtaban, CEO of the Kermanshah Cancer Patient Support Charity, noted that some cancer patients are forced to sell essential household items, such as refrigerators and televisions, to afford treatment.
Systemic liquidity issues are intensifying. Outstanding claims from public and private sectors have reached 267 trillion tomans. Furthermore, insurance payment delays to pharmacies have extended from 6–7 months to as long as 12–13 months, creating a ripple effect throughout the supply chain.
Seasonal influenza vaccine supplies have also faced significant delays due to global production issues, sanctions, and logistics. To mitigate shortages, Iran has turned to alternative procurement from China and Russia, with officials expecting availability in the formal network by October. Officials attribute ongoing difficulties to a combination of international sanctions, banking restrictions, and domestic economic mismanagement.
Entities
Iran Food and Drug Administration · Iran · World Health Organization · China · Russia
Claims
What the coverage asserts, and how many sources carry each claim.
Coverage disagrees
Sources make claims that cannot both be true. CLSTR reports the disagreement; it does not decide who is right.
-
"The Food and Drug Administration plans to supply 2.8 million doses of influenza vaccine."
vs
"The first phase of influenza vaccine distribution included approximately 700,000 doses."
One claim states the first phase of influenza vaccine distribution included 700,000 doses, while the other states the FDA plans to supply 2.8 million doses, which may conflict depending on whether the
- [DISPUTED] The first phase of influenza vaccine distribution included approximately 700,000 doses.
- [DISPUTED] The Food and Drug Administration plans to supply 2.8 million doses of influenza vaccine.
- [● 5 SOURCES] Influenza vaccines sold on the black market for 10 to 15 million Tomans are unapproved and lack quality assurance.
- [● 3 SOURCES] The approved price for influenza vaccines in pharmacies is 2,185,000 Tomans.
- [● 3 SOURCES] Iran is sourcing influenza vaccines from Russia and China due to difficulties securing European supplies.
- [● 2 SOURCES] The pharmaceutical sector is struggling with sanctions, inflation, and economic constraints.
- [● 2 SOURCES] Average medicine prices in Iran have increased by approximately 103 percent since the start of the current year.
- [○ 1 SOURCE] Pharmacies are owed approximately 77 trillion tomans by insurance organizations as of August 2026.
- [○ 1 SOURCE] Checks totaling 8 trillion tomans from pharmacy institutions have bounced.
- [○ 1 SOURCE] Private pharmacies provide approximately 80 percent of pharmaceutical services in the country.
- [○ 1 SOURCE] There are 4,300 pharmacies operating in Tehran province.
- [○ 1 SOURCE] Many pharmacies in Tehran province face potential closure due to financial difficulties.
Timeline
-
[HEALTH] 2 sourcesIran drug supply chain faces instability due to payment delays
Iran's drug supply chain is struggling as insurance payment delays have extended to 13 months, compounded by banking sanctions and foreign currency transfer restrictions.
-
[HEALTH] 2 sourcesIran's Food and Drug Organization addresses thalassemia medication access
Iran's Food and Drug Organization reports that most thalassemia medications are supplied domestically to ensure insurance coverage, while foreign brand imports face limitations due to currency transfer issues.
-
[HEALTH] 2 sourcesIran healthcare crisis worsens as medical costs soar
Iran's healthcare system is in crisis as rising costs and medicine shortages force patients to pay 80% of expenses out of pocket, leading to extreme financial hardship and preventable deaths.
-
[HEALTH] 2 sourcesIran pharmaceutical supply chain faces currency and logistics hurdles
Iran's Food and Drug Administration reports that currency, banking, and logistical challenges, exacerbated by sanctions, are the main causes of delays and rising costs for pharmaceutical raw materials.
-
[BUSINESS] 2 sourcesIran Health Minister warns of antibiotic misuse and industry liquidity issues
Iran's Health Minister warns against excessive antibiotic prescriptions and calls for better drug consumption culture and improved liquidity for pharmaceutical companies.
-
[HEALTH] 10 sourcesIran begins influenza vaccine distribution amid medication crisis
Iran has started distributing influenza vaccines, sourcing doses from China and Russia. Officials warn against black market vaccines costing up to 15 million Tomans amid a broader national medication price hike
-
[HEALTH] 2 sourcesIran faces influenza vaccine supply delays
Iran's Ministry of Health reports influenza vaccine supply delays due to sanctions, rising costs, and logistics, turning to China and Russia as alternative sources while warning against unofficial vendors.
-
[INTERNATIONAL] 5 sourcesIran faces medical shortages amid sanctions and inflation
US sanctions and inflation in Iran are causing severe shortages of life-saving medications, forcing patients with chronic illnesses to underdose or sell belongings to afford treatment.
-
[HEALTH] 3 sourcesIran turns to China and Russia for influenza vaccines
Iran is turning to Chinese and Russian suppliers for influenza vaccines after European companies failed to meet supply commitments and sanctions complicated procurement.
-
[HEALTH] 3 sourcesIran pharmaceutical industry faces massive unpaid claims and patient hardship
Iran's pharmaceutical industry faces 267 trillion tomans in unpaid claims, causing drug shortages and forcing cancer patients to sell household goods to afford essential treatments.
-
[HEALTH] 2 sourcesIran Food and Drug Administration addresses medicine supply and currency allocation
Iran's Food and Drug Administration officials state that currency allocation changes will not affect essential medicine supplies and emphasize the need to strengthen domestic pharmaceutical production.
-
[HEALTH] 3 sourcesIran faces influenza vaccine delays due to global supply issues
Iran faces influenza vaccine shortages due to global manufacturing delays caused by late strain identification by the WHO and supply prioritization for Western markets.
-
[HEALTH] 3 sourcesIran faces shortages of specialized and vital medicines
Iran faces ongoing shortages of specialized and vital medicines, including Factor XIII for hemophilia patients, despite an overall decrease in the number of essential drug shortages compared to 2022.
-
[HEALTH] 5 sourcesIran influenza vaccine supply expected by late September
Iran expects influenza vaccines to be available by late September or early October following delays caused by sanctions, financial transfer issues, and the cessation of domestic production.
-
[BUSINESS] 8 sourcesIran pharmacies face crisis over unpaid insurance claims
Iran's pharmacies face a liquidity crisis due to 77 trillion tomans in unpaid insurance claims and bounced checks, threatening the country's drug supply chain and the survival of private pharmacies.
-
[HEALTH] 2 sourcesIran pharmaceutical industry faces supply chain and liquidity crisis
Iran's pharmaceutical industry faces shortages and instability driven by liquidity crises, raw material transport disruptions, and massive unpaid claims within the supply chain.
-
[BUSINESS] 3 sourcesIran's National Iranian Oil Company accounts frozen over debt
Iran's Bank of Industry and Mine froze National Iranian Oil Company accounts over a $17 billion debt, raising concerns about the oil sector's stability and possible impacts on Strait of Hormuz traffic.
Sources
abc17news.com · aftabnews.ir · bourse24.ir · chn.ir · daroovasalamat.ir · egyptindependent.com · fr.iranfocus.com · gadgetnews.net · gilkhabar.ir · iranfocus.com · iranmedicalinfo.com · irannewsupdate.com · keyt.com · khabarfoori.com · krdo.com · kvia.com · negarmag.com · noandish.com · rokna.net · tarabaran.com · tebtab.ir
This summary has been updated 24 times: see revision history